Histogenics (HSGX) Trading Down 5.6%
Histogenics Corp (NASDAQ:HSGX) shares traded down 5.6% during mid-day trading on Thursday . The stock traded as low as $0.17 and last traded at $0.17. 2,359,022 shares were traded during trading, a decline of 77% from the average session volume of 10,138,614 shares. The stock had previously closed at $0.18.
Several large investors have recently bought and sold shares of HSGX. Geode Capital Management LLC bought a new position in shares of Histogenics during the 4th quarter worth about $25,000. Virtu Financial LLC increased its stake in Histogenics by 505.8% in the first quarter. Virtu Financial LLC now owns 592,976 shares of the biotechnology company’s stock valued at $69,000 after acquiring an additional 495,096 shares during the period. Finally, Sabby Management LLC bought a new stake in Histogenics in the first quarter valued at about $220,000. Institutional investors own 6.17% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dailypolitical.com/2019/05/25/histogenics-hsgx-trading-down-5-6.html.
About Histogenics (NASDAQ:HSGX)
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Recommended Story: What is a Reverse Stock Split?
Receive News & Ratings for Histogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Histogenics and related companies with MarketBeat.com's FREE daily email newsletter.